Comments

Metagenomi Stock Price, Quotes and Forecasts

Q: What sector and industry does Metagenomi (MGX) operate in?

Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MGXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.05

0.031.49%

At close: -

$2.10

0.052.44%

After Hours: 7:47 PM EDT

Metagenomi (MGX) Forecast

News Earnings Metagenomi (MGX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Metagenomi Stock Price, Quotes and Forecasts | NASDAQ:MGX | Benzinga

Explore Metagenomi stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MGX.

Open	$2.03
Close	$2.05
Volume / Avg.	201.16K / 1.19M
Day Range	$1.98 - $2.08
52 Wk Range	1.61 - 12.10
Market Cap	$78.59M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	9.81%
Days to Cover	5.66

Recent News

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Cogent Communications To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars

Moderna reports Q1 loss, beating sales estimates amidst declining COVID-19 vaccine demand. Cost-saving measures drive optimism for investors. CEO Stéphane Bancel eyes strategic investments. Guidance reaffirms $4 billion sales target for 2024.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.03
Close	$2.05
Volume / Avg.	201.16K / 1.19M
Day Range	$1.98 - $2.08
52 Wk Range	1.61 - 12.10
Market Cap	$78.59M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	9.81%
Days to Cover	5.66

About Metagenomi Inc.

Sector

Health Care

Industry

Biotechnology

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for pati...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Metagenomi (MGX) stock?

You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.

View our list of the best stock brokerages

Who are Metagenomi (MGX) competitors?

Other companies in Metagenomi’s space includes: Zura Bio (NASDAQ:ZURA), Skye Bioscience (NASDAQ:SKYE), Inozyme Pharma (NASDAQ:INZY), PepGen (NASDAQ:PEPG) and Armata Pharmaceuticals (AMEX:ARMP).

What is the forecast, or price target, for Metagenomi (MGX) stock?

Metagenomi has a consensus price target of $16.67.

What is the current price for Metagenomi (MGX)?

The stock price for Metagenomi (NASDAQ: MGX) is $2.1 last updated March 12, 2025 at 7:47 PM EDT.

Does Metagenomi (MGX) pay a dividend?

There are no upcoming dividends for Metagenomi.

When is Metagenomi (NASDAQ:MGX) reporting earnings?

Metagenomi’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Metagenomi (MGX) going to split?

There is no upcoming split for Metagenomi.

What sector and industry does Metagenomi (MGX) operate in?

Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.